DE LUCA, Elisa
DE LUCA, Elisa
Struttura Didattica Speciale di Biotecnologie
Boron dipyrromethene (BODIPY) functionalized carbon nano-onions for high resolution cellular imaging
2014-01-01 Bartelmess, Juergen; De Luca, Elisa; Signorelli, Angelo; Baldrighi, Michele; Becce, Michele; Brescia, Rosaria; Nardone, Valentina; Parisini, Emilio; Echegoyen, Luis; Pompa, Pier Paolo; Giordani, Silvia
Characterization of the cellular functions of KRIT1, the disease gene responsible for type 1 Cerebral Cavernous Malformations (CCM1)
2007-01-01 AVOLIO M; FRANCALANCI F; DEGANI S; BALZAC F; GOITRE L; DE LUCA E; MARINO M; RECUPERO D; ORSO F; TAVERNA D; RETTA S
Intracellular antioxidant activity of biocompatible citrate-capped palladium nanozymes
2020-01-01 Moglianetti M.; Pedone D.; Udayan G.; Retta S.F.; Debellis D.; Marotta R.; Turco A.; Rella S.; Malitesta C.; Bonacucina G.; De Luca E.; Pompa P.P.
Krit1 contains a PTB domain that acts as a passport for nuclear translocation
2006-01-01 AVOLIO M; FRANCALANCI F; DE LUCA E; MARINO M; DEGANI S; BALZAC F; TARONE G; RETTA S
KRIT1 loss of function causes a ROS-dependent upregulation of c-Jun
2014-01-01 L. Goitre; E. De Luca; S. Braggion; E. Trapani; M. Guglielmotto; F. Biasi; M. Forni; A. Moglia; L. Trabalzini; S.F. Retta
KRIT1 loss-of-function causes a ROS-dependent upregulation of transcription factors involved in oxidative stress responses
2013-01-01 Goitre L.; De Luca E.; Braggion S.; Forni M.; Moglia A.; Retta SF
Krit1 meets partners in distinct subcellular compartments through its “FERM” domain
2006-01-01 FRANCALANCI F; AVOLIO M; FERRO E; MARINO M; DE LUCA E; DEGANI S; BALZAC F; TARONE G; RETTA S
Krit1 meets partners in distinct subcellular compartments through its “FERM” domain
2006-01-01 FRANCALANCI F; AVOLIO M; FERRO E; MARINO M; DE LUCA E; DEGANI S; BALZAC F; TARONE G; TRABALZINI L.; RETTA S
KRIT1 regulates cell adhesion by controlling ICAP1A functions and cytoskeleton dynamics
2008-01-01 De Luca E.; Avolio M.; Francalanci F.; Marino M.; Degani S.; Balzac F.; Goitre L.; Sgrò F.; Tarone G.; Retta S.F.
KRIT1, a protein involved in Cerebral Cavernous Malformation pathogenesis, is a target of oxidative stress
2007-01-01 MARINO M; GOITRE L; FRANCALANCI F; AVOLIO M; DE LUCA E; SGR F; BALZAC F; TARONE G; RETTA S
KRIT1, the disease gene responsible for type 1 Cerebral Cavernous Malformations (CCM1), acts as a modulator of RAP1A and ICAP1A functions
2007-01-01 AVOLIO M; FRANCALANCI F; DEGANI S; DE LUCA E; MARINO M; GOITRE L; RECUPERO D; BALZAC F; RETTA S
Krit1: a nucleocytoplasmic shuttling protein associated with Cerebral Cavernous Malformations
2005-01-01 AVOLIO M; FRANCALANCI F; DEGANI S; MARINO M; DE LUCA E; FRAIOLI F; BALZAC F; S. RETTA
Krit1A and Krit1B isoforms are characterized by distinct subcellular localizations and functions
2007-01-01 AVOLIO M; FRANCALANCI F; DE LUCA E; SGR F; DEGANI S; BALZAC F; TARONE G; RETTA S
KRIT1A, a protein involved in the human disease Cerebral Cavernous Malformation, is a molecular sensor for oxidative stress
2008-01-01 Marino M.; Francalanci F.; Avolio M.; De Luca E.; Balzac F.; Degani S.; Goitre L.; Sgrò F.; Tarone G.; Retta S.F.
Monocytes of patients with Amyotrophic Lateral Sclerosis linked to gene mutations display altered TDP-43 subcellular distribution
2017-01-01 De Marco, Giovanni; Lomartire, Annarosa; Calvo, Andrea; Risso, Alessandra; De Luca, Elisa; Mostert, Michael; Mandrioli, Jessica; Caponnetto, Claudia; Borghero, Giuseppe; Manera, Umberto; Canosa, Antonio; Moglia, Cristina; Restagno, Gabriella; Fini, Nicola; Tarella, Corrado; Giordana, Maria Teresa; Rinaudo, Maria Teresa; Chiò, Adriano
MRI tracking of macrophages labeled with glucan particles entrapping a water insoluble paramagnetic Gd-based agent
2013-01-01 S. Figueiredo; J. C. Cutrin; S. Rizzitelli; E. De Luca; J. N. Moreira; C. F. G. C. Geraldes; S. Aime; E. Terreno
Multifunctional platinum@bsa-rapamycin nanocarriers for combinatorial therapy of cerebral cavernous malformation disease
2019-01-01 Perrelli, A; De Luca, E; Pedone, D; Moglianetti, M; Fornelli, C; Zotta, A; Pulcini, D; Pompa, PP; Retta, SF
Multifunctional Platinum@BSA-Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation
2018-01-01 De Luca, Elisa; Pedone, Deborah; Moglianetti, Mauro; Pulcini, Daniele; Perrelli, Andrea; Retta, Saverio Francesco; Pompa, Pier Paolo
p140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation.
2012-01-01 Damiano L; Le Dévédec SE; Di Stefano P; Repetto D; Lalai R; Truong H; Xiong JL; Danen EH; Yan K; Verbeek FJ; De Luca E; Attanasio F; Buccione R; Turco E; van de Water B; Defilippi P
PI3K Class II α Controls Spatially Restricted Endosomal PtdIns3P and Rab11 Activation to Promote Primary Cilium Function.
2014-01-01 Franco I;Gulluni F;Campa CC;Costa C;Margaria JP;Ciraolo E;Martini M;Monteyne D;De Luca E;Germena G;Posor Y;Maffucci T;Marengo S;Haucke V;Falasca M;Perez-Morga D;Boletta A;Merlo GR;Hirsch E
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| Boron dipyrromethene (BODIPY) functionalized carbon nano-onions for high resolution cellular imaging | 2014 | Bartelmess, Juergen; De Luca, Elisa; Signorelli, Angelo; Baldrighi, Michele; Becce, Michele; Brescia, Rosaria; Nardone, Valentina; Parisini, Emilio; Echegoyen, Luis; Pompa, Pier Paolo; Giordani, Silvia | |
| Characterization of the cellular functions of KRIT1, the disease gene responsible for type 1 Cerebral Cavernous Malformations (CCM1) | 2007 | AVOLIO M; FRANCALANCI F; DEGANI S; BALZAC F; GOITRE L; DE LUCA E; MARINO M; RECUPERO D; ORSO F; TAVERNA D; RETTA S | |
| Intracellular antioxidant activity of biocompatible citrate-capped palladium nanozymes | 2020 | Moglianetti M.; Pedone D.; Udayan G.; Retta S.F.; Debellis D.; Marotta R.; Turco A.; Rella S.; Malitesta C.; Bonacucina G.; De Luca E.; Pompa P.P. | |
| Krit1 contains a PTB domain that acts as a passport for nuclear translocation | 2006 | AVOLIO M; FRANCALANCI F; DE LUCA E; MARINO M; DEGANI S; BALZAC F; TARONE G; RETTA S | |
| KRIT1 loss of function causes a ROS-dependent upregulation of c-Jun | 2014 | L. Goitre; E. De Luca; S. Braggion; E. Trapani; M. Guglielmotto; F. Biasi; M. Forni; A. Moglia; L. Trabalzini; S.F. Retta | |
| KRIT1 loss-of-function causes a ROS-dependent upregulation of transcription factors involved in oxidative stress responses | 2013 | Goitre L.; De Luca E.; Braggion S.; Forni M.; Moglia A.; Retta SF | |
| Krit1 meets partners in distinct subcellular compartments through its “FERM” domain | 2006 | FRANCALANCI F; AVOLIO M; FERRO E; MARINO M; DE LUCA E; DEGANI S; BALZAC F; TARONE G; RETTA S | |
| Krit1 meets partners in distinct subcellular compartments through its “FERM” domain | 2006 | FRANCALANCI F; AVOLIO M; FERRO E; MARINO M; DE LUCA E; DEGANI S; BALZAC F; TARONE G; TRABALZINI L.; RETTA S | |
| KRIT1 regulates cell adhesion by controlling ICAP1A functions and cytoskeleton dynamics | 2008 | De Luca E.; Avolio M.; Francalanci F.; Marino M.; Degani S.; Balzac F.; Goitre L.; Sgrò F.; Tarone G.; Retta S.F. | |
| KRIT1, a protein involved in Cerebral Cavernous Malformation pathogenesis, is a target of oxidative stress | 2007 | MARINO M; GOITRE L; FRANCALANCI F; AVOLIO M; DE LUCA E; SGR F; BALZAC F; TARONE G; RETTA S | |
| KRIT1, the disease gene responsible for type 1 Cerebral Cavernous Malformations (CCM1), acts as a modulator of RAP1A and ICAP1A functions | 2007 | AVOLIO M; FRANCALANCI F; DEGANI S; DE LUCA E; MARINO M; GOITRE L; RECUPERO D; BALZAC F; RETTA S | |
| Krit1: a nucleocytoplasmic shuttling protein associated with Cerebral Cavernous Malformations | 2005 | AVOLIO M; FRANCALANCI F; DEGANI S; MARINO M; DE LUCA E; FRAIOLI F; BALZAC F; S. RETTA | |
| Krit1A and Krit1B isoforms are characterized by distinct subcellular localizations and functions | 2007 | AVOLIO M; FRANCALANCI F; DE LUCA E; SGR F; DEGANI S; BALZAC F; TARONE G; RETTA S | |
| KRIT1A, a protein involved in the human disease Cerebral Cavernous Malformation, is a molecular sensor for oxidative stress | 2008 | Marino M.; Francalanci F.; Avolio M.; De Luca E.; Balzac F.; Degani S.; Goitre L.; Sgrò F.; Tarone G.; Retta S.F. | |
| Monocytes of patients with Amyotrophic Lateral Sclerosis linked to gene mutations display altered TDP-43 subcellular distribution | 2017 | De Marco, Giovanni; Lomartire, Annarosa; Calvo, Andrea; Risso, Alessandra; De Luca, Elisa; Mostert, Michael; Mandrioli, Jessica; Caponnetto, Claudia; Borghero, Giuseppe; Manera, Umberto; Canosa, Antonio; Moglia, Cristina; Restagno, Gabriella; Fini, Nicola; Tarella, Corrado; Giordana, Maria Teresa; Rinaudo, Maria Teresa; Chiò, Adriano | |
| MRI tracking of macrophages labeled with glucan particles entrapping a water insoluble paramagnetic Gd-based agent | 2013 | S. Figueiredo; J. C. Cutrin; S. Rizzitelli; E. De Luca; J. N. Moreira; C. F. G. C. Geraldes; S. Aime; E. Terreno | |
| Multifunctional platinum@bsa-rapamycin nanocarriers for combinatorial therapy of cerebral cavernous malformation disease | 2019 | Perrelli, A; De Luca, E; Pedone, D; Moglianetti, M; Fornelli, C; Zotta, A; Pulcini, D; Pompa, PP; Retta, SF | |
| Multifunctional Platinum@BSA-Rapamycin Nanocarriers for the Combinatorial Therapy of Cerebral Cavernous Malformation | 2018 | De Luca, Elisa; Pedone, Deborah; Moglianetti, Mauro; Pulcini, Daniele; Perrelli, Andrea; Retta, Saverio Francesco; Pompa, Pier Paolo | |
| p140Cap suppresses the invasive properties of highly metastatic MTLn3-EGFR cells via impaired cortactin phosphorylation. | 2012 | Damiano L; Le Dévédec SE; Di Stefano P; Repetto D; Lalai R; Truong H; Xiong JL; Danen EH; Yan K; Verbeek FJ; De Luca E; Attanasio F; Buccione R; Turco E; van de Water B; Defilippi P | |
| PI3K Class II α Controls Spatially Restricted Endosomal PtdIns3P and Rab11 Activation to Promote Primary Cilium Function. | 2014 | Franco I;Gulluni F;Campa CC;Costa C;Margaria JP;Ciraolo E;Martini M;Monteyne D;De Luca E;Germena G;Posor Y;Maffucci T;Marengo S;Haucke V;Falasca M;Perez-Morga D;Boletta A;Merlo GR;Hirsch E |